Your session is about to expire
← Back to Search
CBT + HIV Risk Reduction for Social Anxiety (SC-RCT Trial)
SC-RCT Trial Summary
This trial will provide the first efficacy data for a novel and innovative HIV prevention intervention for MSM that combines the most empirically supported treatment for social anxiety disorder, cognitive-behavioural therapy, with HIV risk reduction counselling.
SC-RCT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSC-RCT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SC-RCT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not currently taking PrEP for HIV prevention.I've had unprotected sex with a potentially HIV-positive partner and used substances before or during sex in the last 3 months.I am a man aged 18 or older.I will inform the study team if I start any new mental health treatments or change my medication.
- Group 1: Applied Relaxation
- Group 2: Cognitive Behavioural Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is registration currently open for this research?
"Affirmative, according to the information on clinicaltrials.gov this medical study is still in its enrollment phase. The trial first appeared online on December 15th 2020 and was last updated April 25th 2022. 176 patients are needed from 1 participating site for completion of the research project."
How many individuals are participating in the current clinical experiment?
"Affirmative. Clinicaltrials.gov displays that this clinical trial is actively recruiting participants, with the initial posting on December 15th 2020 and last update on April 25th 2022. The study aims to enroll 176 patients at a single site."
Share this study with friends
Copy Link
Messenger